USP Compounding Compliance: Teamwork Makes the Dreamwork: Efficient and Effective Hazardous Drug Lists and 503a/b Vendor Assessments Across a Large Health System – On Demand
This activity will present lessons learned about the creation of a facility specific hazardous drug list and achieving compliance with USP Chapter 800 Hazardous Drugs – Handling in Healthcare Settings. The activity will also address who to evaluate outsourced compounding services to ensure quality and patient safety. Common hurdles facilities encounter on the road to compliance will be discussed, as well as different solutions to those obstacles.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Describe the utilization of a collaborative Quality, Safety, and Regulatory Pharmacy Committee across a large health system
- Discuss the process of determining hazardous status of new drugs added to health system formulary
- Illustrate the need for utilizing a 503a/b vendor audit process through a system-wide approach
- Demonstrate the types of tools used during an audit and identify the key members of the audit team
Pharmacy technician learning objectives
- Describe the utilization of a collaborative Quality, Safety, and Regulatory Pharmacy Committee across a large health system
- Discuss the process of determining hazardous status of new drugs added to health system formulary
Additional Information
Attachment | Size |
---|---|
Helpful Tips for Users.pdf | 157.72 KB |
On Demand Activity
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient
Jackie Stokes, BS
Manager, Pharmacy Program
Vizient
Course reviewer
Katrina K. Harper, PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director, Sourcing Operations
Center for Pharmacy Practice Excellence
Presenters
Laura Meleis, PharmD, MS, BCPS
Assistant Director of Pharmacy – Quality, Compliance and Regulatory Affairs
Director, Pharmacy Technician Training Program
Massachusetts General Hospital
Caryn Belisle, RPh, MBA
Director of Pharmacy Regulatory Compliance, Quality and Safety
Brigham Health
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
____________________________________________
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-21-088-H05-P
Universal Activity Number: JA0006103-0000-21-088-H05-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance